HKEX: 3347 - Hangzhou Tigermed Consulting Co., Ltd

Yield per half year: -15.24%
Sector: Healthcare

Hangzhou Tigermed Consulting Co., Ltd

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
8/10
12.89 35.42 -63.6% 38.88 -66.84%
P/S 3.53 7.59 -53.42%
P/BV 1.07 3.68 -71.04%
P/FCF 73.77 55.41 33.14%
Ev/Ebitda 21.43 2.91 636.96%
Ev/S 7.68 23.72 -67.6%
Ev/FCF 67.8 63.79 6.3%
E/P 0.0328 0.0326 0.5766%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
10/10
41.4 -11.9 -447.85% 52.71 -21.46%
ROE 9.96 5.19 92.06%
ROA 7.09 3.47 104.32%
ROIC 0 0 0%
ROS 27.42 -11.49 -338.71%
ROCE 0 6.04 -100%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
9/10
0.9659 0.7755 24.55% 0.4439 117.6%
Nеt Debt/Ebitda 0 0.0128 -100%
Debt/Ratio 0.0953 0.1229 -22.39%
Debt/Equity 1.77 0.8001 121.21%
Debt/Net Income 1.4 1.76 -20.48%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
9.78/10
3.91 2.42 61.7% 1.62 140.72%
Number of years of dividend growth 4 1.21 231.03%
DSI 1 0.563 77.63%
Average dividend growth 30.58 3.2 854.84%
Average percentage for 5 years 1.62 1.82 -10.53%
Average percentage for payments 25.01 23.96 4.39%
Difference from average difference in sector 1.49
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
10/10
163.4 19.4 742.27%
Growth impulse Ebitda 5 years 145.56 -44.8 -424.91%
Growth impulse Net Income 5 years 140.59 80.79 74.02%
Growth impulse FCF 5 years 97.03 76.43 26.95%
Growth impulse EPS 5 years 11.06 -116.84 -109.47%
IP Score
6.87/10

Similar companies

Sinopharm Group Co. Ltd.

Hansoh Pharmaceutical Group Company Limited

WuXi AppTec Co., Ltd.

CSPC Pharmaceutical Group Limited